One Amazing Story

1950-1960

Industry

- Chemical structure of DNA discovered

LabCorp

- Biomedical Laboratories founded in Burlington, North Carolina

1970-1974

Industry

- First regional Tay Sachs screening program implemented

LabCorp

- First scientific specialist joins LabCorp

1975-1979

Industry

- NIH sets age 35 and above as "advanced maternal age" where amniocentesis should be offered

LabCorp

- Chromosome analysis begins

1980-1984

Industry

- First case of AIDS reported in U.S.
- Polymerase chain reaction technology developed

LabCorp

- AFP screening offered
- AIDS testing begins

1985-1989

Industry

- Human genome sequence effort launched

LabCorp

- Center for Molecular Biology & Pathology (CMBP) for molecular-based lab services started

1990-1994

Industry

- ID of genes involved in development of cancers
- ID of genes associated with disorders such as Fragile X

LabCorp

- Oncology testing program launched
- Molecular oncology, molecular genetic testing introduced
- Clinical trials in molecular testing procedures in infectious diseases and oncology performed
- Mitochondrial DNA testing for forensic ID introduced

1995-1999

Industry

- FDA approves Amplicor HIV-Viral Load Kit
- FDA approves targeted immunotherapy for breast cancer, Herceptin
- ACOG recognizes 3 marker screenings as standard of care

LabCorp

- Genetic Design purchased
- Hepatitis C genotyping introduced
- HIV GeneChip technology for HIV genotype studies; genotyping and phenotyping and correlation database introduced
- Partnership with Virco
- Automated PCR testing introduced

2000-2004

Industry

- Human genome sequenced
- ACOG publishes cystic fibrosis testing recommendations

LabCorp

- National Genetics Institute, ViroMed and Dianon acquired
- Partnership with EXACT Sciences, Celera Diagnostics, Myriad Genetics, Correlogic Systems and BioPredictive
- Genosure, PreGen Plus introduced
- Expansion of molecular testing menu

Lab Corp Today

Laboratory Corporation of America® Holdings (LabCorp), an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $4.1 billion in 2007, more than 26,000 employees nationwide, and more than 220,000 clients, LabCorp offers clinical assays, ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, National Genetics Institute, Inc., ViroMed Laboratories, Inc., The Center for Esoteric Testing, DIANON Systems, Inc., US LABS, and Esoterix. Our clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies.